RESUMO
We developed a microfluidic chip setup for capillarity-assisted particle assembly (CAPA). A capillary bridge is formed between the aperture of a silicon chip and the assembly template. The bridge is fed with particle suspension through a microfluidic channel on the chip top side. With this setup, we can control the particle assembly location and tune the suspension composition during particle assembly. In this note, we describe the chip setup, the CAPA process using the microfluidic chip, and results of complex particle assemblies, such as composite particle arrays and particle gradients, that could not be obtained using a conventional CAPA setup.
RESUMO
Enhanced optical transmission (EOT) through a single aperture is usually achieved by exciting surface plasmon polaritons with periodic grooves. Surface plasmon polaritons are only excited by p-polarized incident light, i.e. with the electric field perpendicular to the direction of the grooves. The present study experimentally investigates EOT for s-polarized light. A subwavelength slit surrounded on each side by periodic grooves has been fabricated in a gold film and covered by a thin dielectric layer. The excitation of s-polarized dielectric waveguide modes inside the dielectric film strongly increases the s-polarized transmission. A 25 fold increase is measured as compared to the case without the dielectric film. Transmission measurements are compared with a coupled mode method and show good qualitative agreement. Adding a waveguide can improve light transmission through subwavelength apertures, as both s and p-polarization can be efficiently transmitted.
RESUMO
This is the second part of a two-part review presenting an overview of the molecular findings associated with both benign and malignant chondroid neoplasms. The first part presented a brief review of modern methods in molecular pathology, along with a review of the cytogenetic and molecular genetic findings in benign chondroid neoplasms. This second part reviews the cytogenetic and molecular genetic findings in malignant chondroid neoplasms. Clinical aspects of the various lesions are briefly discussed, and each tumor is illustrated with representative radiographic and pathologic images.
Assuntos
Neoplasias Ósseas/genética , Neoplasias Ósseas/patologia , Condrossarcoma/genética , Condrossarcoma/patologia , Neoplasias Ósseas/classificação , Condrossarcoma/classificação , HumanosRESUMO
This two-part review presents an overview of the molecular findings associated with both benign and malignant chondroid neoplasms. This first part presents a brief review of methods in molecular pathology along with a review of the cytogenetic and molecular genetic findings in benign chondroid neoplasms. Clinical aspects of the various lesions are briefly discussed, and each tumor is illustrated with representative radiographic and pathologic images. Malignant chondroid neoplasms will be considered in the second part of this review.
Assuntos
Neoplasias Ósseas/genética , Neoplasias Ósseas/metabolismo , Condroma/genética , Condroma/metabolismo , Testes Genéticos/métodos , Biomarcadores/metabolismo , Neoplasias Ósseas/diagnóstico , Condroma/diagnóstico , Predisposição Genética para Doença/genética , HumanosRESUMO
A 51-year-old woman presented with nausea, vomiting and weight loss. The diagnosis of superior mesenteric artery syndrome was established by CT and upper-gastrointestinal contrast radiography. This revealed a characteristic dilatation of the first and second parts of the duodenum and an abrupt cutoff in the third part due to vascular compression. The obstruction disappeared when the patient was placed in the left lateral recumbent position. The thin habitus of this patient probably played an important role in the development of the syndrome. She was given dietary and positioning advice and within 4 months relief of symptoms was accompanied by a weight gain of 4 kg.
Assuntos
Síndrome da Artéria Mesentérica Superior/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Radiografia , Síndrome da Artéria Mesentérica Superior/complicações , Síndrome da Artéria Mesentérica Superior/diagnóstico por imagem , Síndrome da Artéria Mesentérica Superior/dietoterapia , Vômito/diagnóstico , Vômito/etiologia , Redução de PesoRESUMO
The case of a 30-year-old woman with multiple loose bodies in the shoulder joint is presented. The patient complained of discomfort of her right shoulder. Conventional radiographs failed to reveal any abnormality of the shoulder. On MRI numerous loose bodies were detected that resembled synovial chondromatosis. Histologically, the loose bodies were composed of a benign fibroblastic lesion with diagnostic features of fibroma of tendon sheath, each surfaced by synoviocytes. The clinicopathologic features of intra-articular fibroma of tendon sheath are reviewed. We propose using the term "synovial fibroma" for tumors with histopathologic features of fibroma of tendon sheath arising in the synovium of joints.
Assuntos
Fibroma/diagnóstico , Corpos Livres Articulares/diagnóstico , Imageamento por Ressonância Magnética , Articulação do Ombro , Tendões/patologia , Adulto , Condromatose Sinovial/diagnóstico , Diagnóstico Diferencial , Feminino , Fibroma/cirurgia , Humanos , Corpos Livres Articulares/cirurgiaRESUMO
Patients with suprasellar lesions develop profound hypothalamic obesity and listlessness with no effective treatment. We added triiodothyronine (T(3)) supplementation in 3 such patients and present their response. All had previous nutritional counseling without benefit. All were treated for diabetes insipidus (DI) and hypopituitarism; serum free thyroxine (T(4)) level was normal. A 24-year-old woman (pineal tumor and astrocytoma) had weight gain (4.7 kg/yr for 3 years), cold intolerance, fatigue, dry skin, and constipation; after T(3), she lost 14 kg over 27 months and reported overall improvement. Her bone mineral density also improved. A 10.6-year-old boy (optic glioma) was gaining 6 kg/yr for 4 years; after T(3) supplement, he lost 4.3 kg over 11 months. A 12-year-old girl (mixed germ cell tumor) had weight gain (8.3 kg/yr for 3 years) and listlessness; after T(3), she lost 8.1 kg over 16 months and had improved alertness. All patients were asymptomatic despite supraphysiologic T(3) levels. We suggest that T(3) may serve as a simple and effective supplement, which can promote weight loss and improve the well being of these patients with hypothalamic obesity.
Assuntos
Neoplasias Encefálicas/complicações , Doenças Hipotalâmicas/complicações , Doenças Hipotalâmicas/tratamento farmacológico , Obesidade/etiologia , Tri-Iodotironina/uso terapêutico , Redução de Peso , Adulto , Criança , Feminino , Humanos , Doenças Hipotalâmicas/etiologia , Masculino , Obesidade/tratamento farmacológico , Resultado do TratamentoRESUMO
OBJECTIVE: Expression of TSG-6 (tumor necrosis factor-stimulated gene 6) is induced by proinflammatory cytokines. This study was undertaken to examine the effects of local expression of TSG-6 in arthritic joints of TSG-6 transgenic mice, in the collagen-induced arthritis (CIA) model. METHODS: We generated transgenic mice that harbored the TSG-6 gene under the control of the T cell-specific lck promoter. Arthritis was induced by immunization with bovine type II collagen (CII), and its progression was monitored based on the incidence of arthritis, the arthritis index, and footpad swelling. Anti-CII antibodies and cytokine production were determined by enzyme-linked immunosorbent assay. Gene expression arrays were used to compare gene expression profiles of transgenic and control mice at various stages of CIA. RESULTS: TSG-6 was expressed in limbs of transgenic mice after immunization with CII, while its expression in nontransgenic animals was insignificant. The incidence of CIA was reduced in TSG-6 transgenic animals, its onset delayed, and all parameters of clinical arthritis significantly reduced. However, the immune response against CII was not significantly inhibited in TSG-6 transgenic mice. CONCLUSION: TSG-6 expression has been demonstrated in patients with rheumatoid and other forms of arthritis. Our data show that local expression of TSG-6 at sites of inflammation results in potent inhibition of inflammation and joint destruction in a model of autoimmune arthritis in mice. Therefore, it is likely that TSG-6 plays a similar modulatory role in human rheumatoid arthritis and related diseases and may have potential for the treatment of autoimmune arthritis in humans.
Assuntos
Artrite/induzido quimicamente , Artrite/genética , Moléculas de Adesão Celular/genética , Colágeno Tipo II , Predisposição Genética para Doença/genética , Animais , Formação de Anticorpos , Artrite/patologia , Artrite/fisiopatologia , Bovinos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Colágeno Tipo II/imunologia , Colágeno Tipo II/farmacologia , Citocinas/biossíntese , Expressão Gênica , Articulações/fisiopatologia , Camundongos , Camundongos Endogâmicos DBA , Camundongos Transgênicos/genética , Linfócitos T/patologia , TransgenesRESUMO
Intracortical osteosarcoma is the rarest type of osteosarcoma. In most instances the tumor arises in the cortex of the femur, less commonly, in the tibia. We describe an 11-year-old patient with intracortical osteosarcoma of the tibia in whom the tumor was present for 2 years and became painful 3 months prior to presentation.
Assuntos
Neoplasias Ósseas/diagnóstico , Osteossarcoma/diagnóstico , Tíbia/patologia , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/cirurgia , Criança , Humanos , Imageamento por Ressonância Magnética , Masculino , Osteossarcoma/diagnóstico por imagem , Osteossarcoma/cirurgia , Fatores de Tempo , Tomografia Computadorizada por Raios XRESUMO
Synovial fibroblasts (SFs) play a critical role in the pathogenesis of rheumatoid arthritis (RA) and are directly involved in joint destruction. Both SF-resident matrix metalloproteases and cathepsins have been implicated in cartilage degradation although their identities and individual contributions remain unclear. The aims of this study were to investigate the expression of cathepsin K in SFs, the correlation between cathepsin K expression and disease severity, and the contribution of cathepsin K to fibroblast-mediated collagen degradation. Immunostaining of joint specimens of 21 patients revealed high expression of cathepsin K in SFs in the synovial lining and the stroma of synovial villi, and to a lesser extent in CD68-positive cells of the synovial lining. Cathepsin K-positive SFs were consistently observed at sites of cartilage and bone degradation. Expression levels of cathepsin K in the sublining and vascularized areas of inflamed synovia showed a highly significant negative correlation with results derived from the Hannover Functional Capacity Questionnaire (r = 0.78, P = 0.003; and r = 0.70, P = 0.012, respectively) as a measure of the severity of RA in individual patients. For comparison, there was no correlation between Hannover Functional Capacity Questionnaire and cathepsin S whose expression is limited to CD-68-positive macrophage-like synoviocytes. The expression of cathepsin K was also demonstrated in primary cell cultures of RA-SFs. Co-cultures of SFs on cartilage disks revealed the ability of fibroblast-like cells to phagocytose collagen fibrils whose intralysosomal hydrolysis was prevented in the presence of a potent cathepsin K inhibitor but not by an inhibitor effective against cathepsins L, B, and S. The selective and critical role of cathepsin K in articular cartilage and subchondral bone erosion was further corroborated by the finding that cathepsin K has a potent aggrecan-degrading activity and that cathepsin K-generated aggrecan cleavage products specifically potentiate the collagenolytic activity of cathepsin K toward type I and II collagens. This study demonstrates for the first time a critical role of cathepsin K in cartilage degradation by SFs in RA that is comparable to its well-known activity in osteoclasts.
Assuntos
Catepsinas/metabolismo , Colágeno/metabolismo , Endopeptidases/metabolismo , Proteínas da Matriz Extracelular , Fibroblastos/enzimologia , Membrana Sinovial/enzimologia , Adulto , Agrecanas , Animais , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Artrite Reumatoide/enzimologia , Artrite Reumatoide/patologia , Western Blotting , Cartilagem/metabolismo , Catepsina K , Catepsinas/imunologia , Bovinos , Células Cultivadas , Feminino , Fibroblastos/citologia , Fibroblastos/ultraestrutura , Humanos , Imuno-Histoquímica , Lectinas Tipo C , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Proteoglicanas/metabolismo , Índice de Gravidade de Doença , Membrana Sinovial/citologia , Membrana Sinovial/ultraestruturaRESUMO
Kostmann's syndrome is a congenital disorder that causes an impairment of myeloid differentiation in the bone marrow characterized by severe neutropenia, which can be treated with recombinant human granulocyte colony-stimulating factor (G-CSF). We present the case of a 13-year-old boy with Kostmann's syndrome who was treated with recombinant human G-CSF from age 3.5 years. His growth and development was normal, although complicated by intermittent infections. Bone mineral density (BMD) measurement revealed severe osteopenia at the spine and hips (lumbar spine BMD 0.486 g/cm(2); Z score -3.6), and he was referred to the Endocrine Service. Relevant laboratory evaluation showed a pretreatment ionized calcium level at the upper limit of normal (1.28 mmol/L; range: 1.13-1.32 mmol/L), suppressed intact parathyroid hormone (iPTH) level (12 pg/mL; range: 10-65 pg/mL), and a low 1,25-dihydroxy vitamin D level (21 pg/mL; range: 24-65 pg/mL). He had evidence of increased bone turnover evidenced by elevated urinary deoxypyridinoline (DPD) cross-links (46.9 nmol/mmol creatinine; range: 2-34 nmol/mmol creatinine) and a simultaneous increase in markers of bone formation with elevated osteocalcin level (200 ng/mL; normal: 20-80 ng/mL) and alkaline phosphatase level (236 IU/mL; normal: 38-126 IU/mL). Because of clinical concern for his skeletal health, bisphosphonate therapy with intravenous pamidronate was initiated. One month after treatment, the iPTH and DPD cross-links were in the normal range (54 pg/mL and 17.7 nmol/mmol creatinine, respectively) and the 1,25-dihydroxy vitamin D level was elevated (111 pg/mL). Four months after treatment, there was a striking increase in BMD at the lumbar spine (+30.86%), femoral necks (left, +20.02%; right, +17.98%), and total hips (left, +18.40%; right, +15.94%). Seven months after bisphosphonate therapy, his biochemical parameters showed a return toward pretreatment levels with increasing urinary DPD cross-links (28.7 nmol/mmol creatinine) and decreasing iPTH (26 pg/mL). However, the BMD continued to increase (8 months posttreatment), but the magnitude of the increment was attenuated (lumbar-spine, +4.8%; left total hip, +1.2% and right total hip +2.4%), relative to BMD at 4 months. Eight months after the initial treatment, his iPTH was suppressed at 14 pg/mL and he again received pamidronate (at a lower dose); 3 months later, he had an additional increase in BMD (lumbar spine +7.4%, left total hip +3.9%, right total hip +2.7%), relative to the previous study. We hypothesize that prolonged administration of G-CSF as treatment for Kostmann's syndrome is associated with increased bone resorption, mediated by osteoclast activation and leading to bone loss. In children, the resulting osteopenia can be successfully managed with antisreorptive bisphosphonate therapy with significant improvement in bone density. Measurements of biochemical parameters of bone turnover can be used to monitor the magnitude and duration of the therapeutic response and the need for BMD reassessment and, perhaps, retreatment.
Assuntos
Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Neutropenia/congênito , Neutropenia/tratamento farmacológico , Adolescente , Doenças Ósseas Metabólicas/diagnóstico , Doenças Ósseas Metabólicas/tratamento farmacológico , Pré-Escolar , Progressão da Doença , Humanos , Contagem de Leucócitos , Masculino , Neutrófilos , Prognóstico , SíndromeRESUMO
The proto-oncogene c-fos has been implicated in the development of both benign and malignant lesions of bone. Although c-fos expression in such lesions has been well studied in transgenic mouse models, less is known about its role in human musculoskeletal pathology. To clarify this relationship, we used in situ hybridization to localize c-fos m-RNA transcripts in 26 fibrous lesions (eight cases of extra-abdominal fibromatosis and six cases each of fibrous dysplasia, fibrosarcoma, and malignant fibrous histiocytoma of bone) as well as six chondrosarcomas and eight conventional high grade osteosarcomas. We found detectable levels of c-fos expression in tissues from each type of lesion tested. Moreover, all fibrous lesions consistently demonstrated high levels of expression in a majority of cells in each lesion. Chondrosarcomas and osteosarcomas exhibited more heterogeneity in c-fos expression than fibrous tissues. Three of six chondrosarcomas showed moderate expression of c-fos while only one of six was considered high. Similarly, only three of eight osteosarcomas had high expression of c-fos. These findings indicate that the expression of c-fos may be important in the development of a broad range of fibrous lesions as well as in bone and cartilaginous tumors. Additionally, this is the first report, to our knowledge, of detectable c-fos m-RNA in human chondrosarcoma.
Assuntos
Neoplasias Ósseas/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Ósseas/genética , Neoplasias Ósseas/patologia , Criança , Pré-Escolar , Condrossarcoma/genética , Condrossarcoma/metabolismo , Condrossarcoma/patologia , Feminino , Fibroma/genética , Fibroma/metabolismo , Fibroma/patologia , Fibrossarcoma/genética , Fibrossarcoma/metabolismo , Fibrossarcoma/patologia , Displasia Fibrosa Óssea/genética , Displasia Fibrosa Óssea/metabolismo , Displasia Fibrosa Óssea/patologia , Histiocitoma Fibroso Benigno/genética , Histiocitoma Fibroso Benigno/metabolismo , Histiocitoma Fibroso Benigno/patologia , Humanos , Hibridização In Situ , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Osteossarcoma/genética , Osteossarcoma/metabolismo , Osteossarcoma/patologia , Proto-Oncogene Mas , Proteínas Proto-Oncogênicas c-fos/genética , RNA Mensageiro/metabolismoAssuntos
Neoplasias Ósseas/diagnóstico , Hemangioendotelioma Epitelioide/diagnóstico , Tíbia/patologia , Biópsia , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Radiografia , Cintilografia , Compostos Radiofarmacêuticos , Medronato de Tecnécio Tc 99m , Tíbia/diagnóstico por imagemRESUMO
Risk factors for shortness of stature in children with neurofibromatosis type 1 (NF-1) include suprasellar lesions, which can lead to growth hormone deficiency (GHD), skeletal deformities, nutritional insufficiency, and methylphenidate use. At our Neurofibromatosis Clinic, we have observed short children growing poorly without these risk factors. This study investigated whether GHD occurs in children with NF-1 in the absence of suprasellar lesions. Of 251 children with NF-1, 112 were at or below the 25th percentile for height (68 were at or below the 10th). Of these, 51 children, 5-16 years of age were short, growing poorly, and without medical or radiologic findings to explain the poor growth. In 19 of 51, we evaluated GH secretion; 15 of 19 had GHD (peak GH level less than 5 ng/mL in most cases). These findings suggest that GHD may be relatively common in short children with NF-1 without suprasellar abnormalities, suggesting an association with NF-1 independent of organic, pituitary damage. Larger cohorts of NF-1 children should be evaluated to clarify whether NF-1 represents a novel etiology of GHD. Also, a careful assessment of GH secretion in children with NF-1 who are growing poorly in the absence of another clinical explanation is warranted.
Assuntos
Nanismo/tratamento farmacológico , Nanismo/genética , Terapia de Reposição Hormonal , Hormônio do Crescimento Humano/deficiência , Hormônio do Crescimento Humano/uso terapêutico , Neurofibromatose 1/complicações , Adolescente , Encéfalo/patologia , Criança , Pré-Escolar , Nanismo/fisiopatologia , Feminino , Hormônio do Crescimento Humano/metabolismo , Humanos , Imageamento por Ressonância Magnética , Masculino , Neurofibromatose 1/patologia , Neurofibromatose 1/fisiopatologia , Resultado do TratamentoRESUMO
BACKGROUND: We reviewed the late complications of therapy in 94 patients with localized, primary rhabdomyosarcoma of the orbit treated on the Intergroup Rhabdomyosarcoma Study (IRS)-III protocol (1984-1991). PROCEDURE: A questionnaire was sent to the institutions that had registered 106 patients with orbital RMS on the IRS-III protocol, seeking information about vision, periocular structures, and growth and development of the 102 survivors. RESULTS: Ninety-four questionnaires were returned. The median follow-up interval was 7.6 years. The affected eye was removed from 13 patients because of local recurrence (N = 10) or other causes (N = 3). Seventy-nine of the eighty-one remaining patients had received radiation therapy. Sixty-five of these seventy-nine patients (82%) developed a cataract, and 43 of them (66%) underwent cataract surgery. Fifty-five patients (70%) had decreased visual acuity. Twenty-four patients had a dry eye, and 22 had chronic keratitis, conjunctivitis, or corneal changes. Strabismus, diplopia, retinopathy, and uveitis were uncommon. The orbit was hypoplastic in 48 of 82 patients assessed (59%). Ptosis and enophthalmos were reported in 22 patients. Decreased statural growth was noted in 13 of the 53 irradiated patients aged 3-14 years at diagnosis with sufficient data (24%). CONCLUSIONS: The overall survival rate was 96% (102/106). The eye was preserved in 86% of the patients, but vision was impaired in 70% of them. Other frequent complications were cataract, orbital hypoplasia, keratoconjunctivitis, and ptosis/enophthalmos. The current IRS-V study recommends decreasing the dose of irradiation and using conformal techniques in an attempt to minimize these complications.
Assuntos
Oftalmopatias/etiologia , Neoplasias Orbitárias/radioterapia , Lesões por Radiação/etiologia , Rabdomiossarcoma/radioterapia , Adolescente , Adulto , Antineoplásicos/uso terapêutico , Estatura/efeitos da radiação , Catarata/etiologia , Criança , Pré-Escolar , Seguimentos , Humanos , Lactente , Recidiva Local de Neoplasia/cirurgia , Órbita/efeitos da radiação , Neoplasias Orbitárias/tratamento farmacológico , Radioterapia/efeitos adversos , Dosagem Radioterapêutica , Rabdomiossarcoma/tratamento farmacológico , Inquéritos e Questionários , Análise de SobrevidaRESUMO
We report a case of synovial chondromatosis of the tibiofibular joint in a 25-year-old woman that was diagnosed by fine-needle aspiration (FNA). The patient presented with pain in the left knee and a mass in the popliteal fossa. Synovial chondromatosis usually presents with joint symptoms and is often associated with intra-articular loose bodies, whereas presentation as a soft tissue mass is unusual and may raise the clinical suspicion of malignant neoplasm. The diagnosis is commonly confirmed by histopathologic examination of biopsy or excision of the specimen. To the best of our knowledge, this is the first case of synovial chondromatosis of a large joint successfully diagnosed by FNA. Two cases of synovial chondromatosis of the temporomandibular joint have been reported in which the diagnosis was suspected on the basis of FNA. In both these cases, the final diagnosis was established by histopathology of the excised specimens.
Assuntos
Condromatose/diagnóstico , Condromatose/patologia , Articulações/patologia , Adulto , Biópsia por Agulha , Feminino , Humanos , Membrana Sinovial/patologiaRESUMO
OBJECTIVE: To examine the effect of recombinant TSG-6 on collagen-induced arthritis (CIA) in DBA/1J mice. TSG-6 is a tumor necrosis factor (TNF)/ interleukin-1 (IL-1)-inducible hyaluronan-binding protein produced by synovial cells and chondrocytes that is present in synovial fluids of patients with rheumatoid arthritis. METHODS: To determine the effect of TSG-6 on chronic inflammatory joint disease, we induced CIA in DBA/1J mice by immunization with bovine type II collagen. Animals were treated with 12 intraperitoneal doses of 200 microg of recombinant TSG-6, beginning 3 days before the expected onset of disease symptoms. Progression of arthritis was monitored by determining the disease incidence, arthritis index, and footpad swelling. Levels of IgG1, IgG2a, and IgG2b antibodies against bovine and murine type II collagen and serum concentrations of IL-6 were determined at various time points. Histologic examination of affected joints was performed approximately 20 days after the onset of arthritis. RESULTS: Treatment with recombinant TSG-6 protein had a potent ameliorative effect, manifested by decreases in the disease incidence, arthritis index, and footpad swelling. Histologic examination of affected joints in TSG-6-treated animals revealed little pannus formation and cartilage erosion, features which were conspicuous in control mice. Animals treated with recombinant TSG-6 developed significantly reduced levels of IgG1, IgG2a, and IgG2b antibodies against bovine and murine type II collagen. CONCLUSION: The antiinflammatory effect of the TNF/IL-1-inducible TSG-6 protein in murine CIA suggests a role for this protein as an endogenous regulator of the inflammatory process.
Assuntos
Artrite/tratamento farmacológico , Moléculas de Adesão Celular/uso terapêutico , Colágeno/imunologia , Interleucina-1/fisiologia , Fator de Necrose Tumoral alfa/fisiologia , Animais , Anticorpos/sangue , Artrite/induzido quimicamente , Artrite/patologia , Interleucina-6/sangue , Masculino , Camundongos , Camundongos Endogâmicos DBA , Proteínas Recombinantes/uso terapêuticoRESUMO
ABSTRACT The capacity of the microflora in rockwool to suppress Pythium aphanidermatum, the causative agent of root and crown rot in cucumber, was assessed. Disease development of cucumber (Cucumis sativus) grown on rockwool was evaluated in an "ebb-and-flood" system with a recirculating nutrient solution after inoculation with P. aphanidermatum. In five independent experiments from 1995 to 1998, 11 batches of used rockwool were tested. All batches without P. aphanidermatum problems in the preceding cucumber crop had significantly lower numbers of diseased plants in nonautoclaved than in autoclaved used rockwool; the disease incidence was reduced by 52 to 100%. Suppressiveness also was present in rockwool previously used to grow other vegetable crops. Rockwool originating from a cucumber crop that was severely attacked by Pythium resulted in a high disease incidence. Previously unused (new) rockwool had higher or similar percentages of diseased plants than did nonsterilized used rockwool. Disease suppression in used rockwool could also be measured in a smaller test system. In both systems, autoclaved rockwool became suppressive to Pythium after recolonization with the indigenous microflora. Population sizes of total culturable aerobic bacteria as well as of fluorescent pseudomonads did not correlate with disease suppressiveness, as numbers of bacteria and pseudomonads were similar or lower in nonautoclaved (suppressive) than in autoclaved (nonsuppressive) rockwool. Differences in the structure of the bacterial populations could be visualized by using eubacterial polymerase chain reaction (PCR) followed by denaturing gradient gel electrophoresis (DGGE). Interestingly, the nonautoclaved and the recolonized used rockwool, which were both suppressive, showed different dominating bacterial groups as compared with the autoclaved rockwool. PCR-DGGE patterns obtained at different sampling times showed that the composition of the bacterial populations changed during plant growth. Fungal populations were present in the treatments that yielded suppressive rockwool, i.e., the nonautoclaved and the recolonized rockwool, but they were absent or present in low numbers in the autoclaved rockwool, which permitted a high disease incidence. Suppressiveness of rockwool to Pythium root and crown rot is a hitherto undescribed phenomenon, and knowledge of the mechanism and microorganisms involved will stimulate the development of microbially balanced soilless growing systems.
RESUMO
BACKGROUND: This review of children and adolescents with nonorbital soft-tissue sarcoma of the head and neck was undertaken to describe late sequelae of treatment, as manifested primarily by problems with statural growth, facial and nuchal symmetry, dentition, vision and hearing, and school performance. PROCEDURE: Four hundred sixty-nine patients entered the IRS-II and -III protocols with localized, nonorbital soft-tissue sarcomas of the head and neck from 1978 through 1987. Their overall survival rate was 53% (250/469) at 5 years. Two hundred thirteen patients were surviving relapse-free 5 or more years after diagnosis, for whom there were serial height measurements at 2 or more years after initiation of therapy. Their median age at diagnosis was 5 years; the median length of follow-up was 7 years. All received multiple-agent chemotherapy, and all but 3 received irradiation to the primary tumor volume. Sixty-eight percent of the tumors arose in cranial parameningeal sites, 22% in nonparameningeal sites, and 10% in the neck. We reviewed flow sheets submitted to the IRS Group Statistical Office to ascertain which late sequelae were recorded. RESULTS: One hundred sixty-four patients (77%) had one or more problems recorded. One hundred ninety of the two hundred thirteen patients (89%) were under 15 years of age at study entry, and at follow-up 92 (48%) had failed to maintain their initial height velocity, which had decreased by more than 25 percentile points from the original value. Thirty-six of the one hundred ninety patients (19%) were receiving growth hormone injections. Hypoplasia or asymmetry of tissues in the primary tumor site was reported in 74 patients, and 13 underwent reconstructive surgery. Poor dentition or malformed teeth were noted in 61 patients. Impaired vision developed in 37 patients, owing primarily to cataracts, corneal changes, and optic atrophy. Thirty-six patients had decreased hearing acuity, and 9 were fitted with hearing aids; 5 of these 9 had received cisplatin. Thirty-five patients were noted to have problems learning in school. Four patients developed a second malignancy (two sarcomas, one carcinoma, one leukemia). CONCLUSIONS: Late sequelae affected the majority of these patients treated for soft-tissue sarcoma of the head and neck on IRS-II and -III. The potential impact of certain sequelae could be reduced by specific measures, such as surgical reconstruction and hormonal therapy. Late sequelae must be taken into account in designing future curative treatments.